Examples of using Summarised in table in English and their translations into Portuguese
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Responses are summarised in Table 5.
Adverse reactions in these two pivotal studies are summarised in Table 2.
Key data are summarised in Table 2.
The study efficacy results for these patients are summarised in Table 21.
Overall survival is summarised in Table 2 for the ITT population.
The results of study 2011-003 are summarised in table 7.
Progression Free Survival is summarised in Table 1 for the ITT population.
The 24-week results for the three assessment tools are summarised in Table 2.
Efficacy results are summarised in Table 2.
Overall costs andbenefits of the implementation of the measures proposed in the Strategy are summarised in Table 1.
Efficacy results are summarised in Table 7.
The frequencies of ADRs reported with MabThera alone orin combination with chemotherapy are summarised in Table 1.
The results are summarised in Table 3.
Patients demographics andmain disease characteristics are summarised in Table 8.
The key outcomes from RADIANCE are summarised in Table 6 and Figure 5.
Data on antibody persistence one year after the two doses at 13 and15 months of age are also summarised in Table 4.
Results of this study are summarised in table 3.
Adverse reactions from two pivotal studies of saquinavir soft capsule(1000 mg twice daily) used in combination with low dose ritonavir(100 mg twice daily)for at least 48 weeks are summarised in Table 2.
The results of this study are summarised in Table 16.
Results of comparisons of the primary andsecondary efficacy variables are summarised in Table 1.
Baseline characteristics are summarised in Table 5.
The efficacy results from the monotherapy andcombination therapy studies are summarised in Table 4.
Main demographics andoutcomes are summarised in Table 5.
Efficacy results from the primary analysis anda post-hoc analysis with 6-months additional follow up are summarised in Table 8.
Baseline demographics andoutcomes are summarised in Table 4.
The signs andsymptoms associated with hypersensitivity to abacavir are summarised in Table 1.
The 48-week results for the two assessment tools are summarised in Table 4.
Patient demographics andbaseline disease characteristics are summarised in Table 10.
ADRs reported in adult patients treated with rilpivirine are summarised in Table 2.
The mean reduction from baseline in IOP ranged from 7.1 to 8.2 mmHg as summarised in Table 3.